Showing results (31-40 of 48) with videos related to

Sort By:
Pageof 5
European Journal of Medicinal Chemistry|February 23, 2016
Rational design in search for 5-phenylhydantoin selective 5-HT7R antagonists. Molecular modeling, synthesis and biological evaluationKatarzyna Kucwaj-Brysz, Dawid Warszycki, Sabina Podlewska, et al.
European Journal of Medicinal Chemistry|November 22, 2011
Neuroprotective efficacy of quinazoline type phosphodiesterase 7 inhibitors in cellular cultures and experimental stroke modelMiriam Redondo, Juan G Zarruk, Placido Ceballos, et al.
European Journal of Medicinal Chemistry|January 13, 2023
8-Amide and 8-carbamate substitution patterns as modulators of 7-hydroxy-4-methylcoumarin's antidepressant profile: Synthesis, biological evaluation and docking studiesMaria J Matos, Paula Novo, Lucía Mayán, et al.
Scientific Reports|September 9, 2017
Development of Fluorescent Probes that Target Serotonin 5-HT2B ReceptorsJhonny Azuaje, Paula López, Alba Iglesias, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|February 13, 2026
Discovery of first-in-class melanostatin-based ago-allosteric modulators of the dopamine D2 receptorsHugo F Costa-Almeida, Xavier C Correia, Sara C Silva-Reis, et al.
International Journal of Molecular Sciences|April 3, 2021
The PI3Kδ Inhibitor Idelalisib Diminishes Platelet Function and Shows Antithrombotic PotentialMaría N Barrachina, Irene Izquierdo, Lidia Hermida-Nogueira, et al.
Thrombosis and Haemostasis|January 5, 2020
A Comprehensive Tyrosine Phosphoproteomic Analysis Reveals Novel Components of the Platelet CLEC-2 Signaling CascadeIrene Izquierdo, María N Barrachina, Lidia Hermida-Nogueira, et al.
Thrombosis and Haemostasis|February 16, 2022
Katacine Is a New Ligand of CLEC-2 that Acts as a Platelet AgonistLuis A Morán, Ying Di, Marcin A Sowa, et al.
Journal of Medicinal Chemistry|November 9, 2017
A Positive Allosteric Modulator of the Serotonin 5-HT2C Receptor for ObesityJavier García-Cárceles, Juan M Decara, Henar Vázquez-Villa, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|March 5, 2024
Exploring Biginelli-based scaffolds as A2B adenosine receptor antagonists: Unveiling novel structure-activity relationship trends, lead compounds, and potent colorectal anticancer agentsRubén Prieto-Díaz, Hugo Fojo-Carballo, Maria Majellaro, et al.
Pageof 5